BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Treatment
11 results:

  • 1. The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.
    Choi JH; Lim I; Byun BH; Kim BI; Choi CW; Kang HJ; Shin DY; Lim SM
    PLoS One; 2022; 17(9):e0273839. PubMed ID: 36156599
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT).
    Özel M; Baskol M; Akalın H; Baskol G
    Cell Biochem Biophys; 2021 Jun; 79(2):349-357. PubMed ID: 33689126
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Chemotherapy with a Pegylated Liposomal Doxorubicin-Containing Regimen in Newly Diagnosed Hodgkin lymphoma Patients.
    Liu W; Yang M; Ping L; Xie Y; Wang X; Zhu J; Song Y
    Cardiovasc Toxicol; 2021 Jan; 21(1):12-16. PubMed ID: 32683546
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Investigation of the Relationship Between
    Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
    Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The conditioned medium of human mesenchymal stromal cells reduces irradiation-induced damage in cardiac fibroblast cells.
    Chen ZY; Hu YY; Hu XF; Cheng LX
    J Radiat Res; 2018 Sep; 59(5):555-564. PubMed ID: 30010837
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. BCL2 Regulates Differentiation of Intestinal Fibroblasts.
    Weder B; Mamie C; Rogler G; Clarke S; McRae B; Ruiz PA; Hausmann M
    Inflamm Bowel Dis; 2018 Aug; 24(9):1953-1966. PubMed ID: 29796658
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States.
    Nabhan C; Zhou X; Day BM; Dawson K; Zelenetz AD; Friedberg JW; Cerhan JR; Link BK; Flowers CR
    Am J Hematol; 2016 Aug; 91(8):770-5. PubMed ID: 27124800
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma.
    Chiaravalloti A; Danieli R; Abbatiello P; Di Pietro B; Travascio L; Cantonetti M; Guazzaroni M; Orlacchio A; Simonetti G; Schillaci O
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1123-32. PubMed ID: 24562647
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.
    Bohers E; Mareschal S; Bouzelfen A; Marchand V; Ruminy P; Maingonnat C; Ménard AL; Etancelin P; Bertrand P; Dubois S; Alcantara M; Bastard C; Tilly H; Jardin F
    Genes Chromosomes Cancer; 2014 Feb; 53(2):144-53. PubMed ID: 24327543
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary colorectal lymphomas: review of the literature.
    Dionigi G; Annoni M; Rovera F; Boni L; Villa F; Castano P; Bianchi V; Dionigi R
    Surg Oncol; 2007 Dec; 16 Suppl 1():S169-71. PubMed ID: 18024019
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The development and application of imatinib.
    Jones RL; Judson IR
    Expert Opin Drug Saf; 2005 Mar; 4(2):183-91. PubMed ID: 15794712
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.